Back to CAPTRUST FINANCIAL ADVISORS CAPTRUST FINANCIAL ADVISORS

SMMTSMMT
14 quarters

Position history for CAPTRUST FINANCIAL ADVISORSCAPTRUST FINANCIAL ADVISORS's holdings in Summit Therapeutics Inc.

CAPTRUST FINANCIAL ADVISORS previously held 0 shares of SMMT (Summit Therapeutics Inc.), worth $0 as of 2023-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$35,000

Total Shares Change

-11,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q3
Latest
Exited
0
-100.0%
$00.0%$1.87
0
2023-Q2
Unchanged
35,926
0.0%
$90,1740.0%$2.51
0
2023-Q1
New
35,926
-
$62,8700.0%$1.63
29
2022-Q4
Exited
0
-100.0%
$00.0%$4.25
0
2022-Q3
Decreased
11,245
-1.8%
$13,0000.0%$1.15
0
2022-Q2
Increased
11,445
+1.8%
$11,0000.0%$0.97
18
2022-Q1
Unchanged
11,245
0.0%
$28,0000.0%$2.58
0
2021-Q4
Unchanged
11,245
0.0%
$30,0000.0%$2.55
0
2021-Q3
Unchanged
11,245
0.0%
$56,0000.0%$4.83
0
2021-Q2
Increased
11,245
+8.1%
$84,0000.0%$7.43
23
2021-Q1
Decreased
10,400
-5.5%
$61,0000.0%$5.60
0
2020-Q4
Unchanged
11,000
0.0%
$52,0000.0%$5.02
0
2020-Q3
Unchanged
11,000
0.0%
$37,0000.0%$3.49
0
2020-Q2
New
11,000
-
$35,0000.0%$3.04
27

Other major holders of SMMT: RENAISSANCE TECHNOLOGIES LLC, Point72 Asset Management, L.P., HSBC HOLDINGS PLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used